Search Results

You are looking at 1 - 10 of 2,235 items for :

  • "diagnosis" x
  • Refine by Access: All x
Clear All
Full access

Breast Cancer Screening and Diagnosis

Therese B. Bevers, Benjamin O. Anderson, Ermelinda Bonaccio, Sandra Buys, Mary B. Daly, Peter J. Dempsey, William B. Farrar, Irving Fleming, Judy E. Garber, Randall E. Harris, Alexandra S. Heerdt, Mark Helvie, John G. Huff, Nazanin Khakpour, Seema A. Khan, Helen Krontiras, Gary Lyman, Elizabeth Rafferty, Sara Shaw, Mary Lou Smith, Theodore N. Tsangaris, Cheryl Williams, and Thomas Yankeelov

Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology NCCN Categories of Evidence and Consensus Category 1: The recommendation is based on high-level evidence (e.g., randomized controlled trials) and there is

Full access

Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology

Therese B. Bevers, Mark Helvie, Ermelinda Bonaccio, Kristine E. Calhoun, Mary B. Daly, William B. Farrar, Judy E. Garber, Richard Gray, Caprice C. Greenberg, Rachel Greenup, Nora M. Hansen, Randall E. Harris, Alexandra S. Heerdt, Teresa Helsten, Linda Hodgkiss, Tamarya L. Hoyt, John G. Huff, Lisa Jacobs, Constance Dobbins Lehman, Barbara Monsees, Bethany L. Niell, Catherine C. Parker, Mark Pearlman, Liane Philpotts, Laura B. Shepardson, Mary Lou Smith, Matthew Stein, Lusine Tumyan, Cheryl Williams, Mary Anne Bergman, and Rashmi Kumar

clinical finding such as a palpable mass; and (2) incremental imaging after a possible abnormal screening mammogram in an asymptomatic woman (also referred NCCN Clinical Practice Guidelines in Oncology : Breast Cancer Screening and Diagnosis, Version 3

Full access

Phyllodes Tumors of the Breast: Natural History, Diagnosis, and Treatment

Melinda L. Telli, Kathleen C. Horst, Alice E. Guardino, Frederick M. Dirbas, and Robert W. Carlson

– 355 . 7. Parker SJ Harries SA . Phyllodes tumours . Postgrad Med J 2001 ; 77 : 428 – 435 . 8. Jacklin RK Ridgway PF Ziprin P . Optimising preoperative diagnosis in phyllodes tumour of the breast . J Clin Pathol 2006 ; 59

Full access

Patterns and Trends in Receipt of Opioids Among Patients Receiving Treatment for Cancer in a Large Health System

Lindsay M. Sabik, Kirsten Y. Eom, Zhaojun Sun, Jessica S. Merlin, Hailey W. Bulls, Patience Moyo, Jennifer A. Pruskowski, G.J. van Londen, Margaret Rosenzweig, and Yael Schenker

overdose deaths throughout the ongoing opioid epidemic. 33 The UPMC Network Cancer Registry identified patients with a first lifetime primary diagnosis of breast, colorectal, or lung cancer from 2013 to 2017 treated at 1 of 13 facilities within the

Full access

Diagnostic and Treatment Considerations When Newly Diagnosed Breast Cancer Coincides With Pregnancy: A Case Report and Review of Literature

Lauren Nye, Timothy K. Huyck, and William J. Gradishar

physicians perceive the diagnosis to be one that puts the life of the mother at odds with that of the fetus, but available data suggest that termination of the pregnancy does not improve the outcome for pregnant women with breast cancer. 4 Often diagnosis is

Full access

Medicare/Medicaid Insurance, Rurality, and Black Race Associated With Provision of Hepatocellular Carcinoma Treatment and Survival

Andrew M. Moon, Hanna K. Sanoff, YunKyung Chang, Jennifer L. Lund, A. Sidney Barritt IV, Paul H. Hayashi, and Karyn B. Stitzenberg

& Population Health Resource. 18 This subset consisted of patients with continuous healthcare enrollment in any health plan for 12 months preceding and 12 months after diagnosis (or death). Patients participating in a Medicare HMO/Advantage plan were excluded

Full access

A Population-Based Study of Morbidity After Pancreatic Cancer Diagnosis

Reith R. Sarkar, Katherine E. Fero, Daniel M. Seible, Neil Panjwani, Rayna K. Matsuno, and James D. Murphy

diagnosis through death, which allows for assessment of patterns of care and hospitalizations over the entire course of a patient’s disease. Study Population A total of 32,475 patients aged ≥66 years diagnosed with histologically confirmed malignant

Full access

Delays in Diagnosis and Treatment of Breast Cancer: A Safety-Net Population Profile

Kshama Jaiswal, Madelyne Hull, Anna L. Furniss, Reina Doyle, Natalia Gayou, and Elizabeth Bayliss

Delays in breast cancer care can result in patient dissatisfaction as well as increased risks of local recurrence and death. 1 – 3 However, no studies have examined the full continuum of care, from presentation to imaging, to diagnosis, to

Full access

Our Experience With Photodynamic Diagnosis and Photodynamic Therapy for Lung Cancer

Harubumi Kato

. Kato shares a backward glance at where PDT has come from and a forward glimpse at where it may be heading. The Birth of Fluorescence Bronchoscopy for Diagnosing Lung Cancer The diagnosis of lung cancer was significantly enhanced by the development

Full access

Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers

Alexander P. Cole, Chang Lu, Marieke J. Krimphove, Julie Szymaniak, Maxine Sun, Sean A. Fletcher, Stuart R. Lipsitz, Brandon A. Mahal, Paul L. Nguyen, Toni K. Choueiri, Adam S. Kibel, Adil H. Haider, and Quoc-Dien Trinh

between insurance coverage at diagnosis and CSM varied in a statistically significant fashion among individuals with ovarian, pancreatic, lung, colorectal, prostate, or breast cancer, which constitute more than half of all cancer deaths in the United